13F Holdings
中文EN

EUDA EUDA Health Holdings Ltd

Services-Health Services · Nasdaq · SEC CIK 1847846 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY70.0%
TTM net income YoY81.9%
TTM EPS YoY84.4%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR—

Margins

Gross margin43.9%
Operating margin-36.3%
Net margin-40.7%
FCF margin-36.7%
EBITDA margin-33.5%

Returns

ROE—
ROA-162.4%
ROIC (approx.)—
Asset turnover4.00x

Leverage & solvency

Liabilities / assets348.6%
Debt / equity—
Current ratio0.18x
Interest coverage-10.84x

Cash quality & payout

Operating cash flow / net income0.88x
Accruals ratio-20.3%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20222022-07-31
Income statement
Revenue$6.82M$4.01M$3.71M$3.76M—
Cost of revenue$3.83M$3.25M$2.86M$2.89M—
Gross profit$2.99M$762,155$842,075$869,999—
R&D expense$249——$17,209—
SG&A expense$4.15M$3.21M$4.27M$5.82M—
Operating income-$2.48M-$17.34M-$3.96M-$12.22M-$1.99M
Interest expense$228,624$44,890$23,225——
Pretax income-$2.73M-$17.64M-$8.43M-$25.03M—
Income tax$41,935-$4,379—-$20,789—
Net income-$2.77M-$15.36M-$10.04M-$24.88M-$1.76M
EBITDA-$2.28M-$17.16M-$3.84M-$12.05M—
EPS (basic)-1.48-9.46-8.77-2.07—
EPS (diluted)-1.48-9.46-8.77-2.07—
Weighted avg. shares (diluted)1.87M1.62M1.15M12.03M—
Balance sheet
Cash & equivalents$345,144$237,605$189,005$57,541$193,546
Receivables$242,613$146,174$237,474$192,851—
Inventory$2,844$128,977———
Current assets$1.04M$762,876$723,441$25.03M$86.78M
PP&E, net$137,294$87,712$6,732$11,526—
Goodwill—$0$0——
Intangibles$161,434$337,295———
Total assets$1.72M$1.70M$1.31M$25.63M$86.78M
Current liabilities$5.84M$4.14M$8.72M$29.12M—
Total liabilities$5.98M$4.27M$8.79M$29.14M$4.73M
Shareholders' equity-$4.25M-$2.55M-$7.50M-$3.52M-$3.72M
Shares outstanding1.89M1.86M24.63M20.19M2.45M
Cash flow statement
Operating cash flow-$2.43M-$2.03M-$2.92M-$1.53M-$1.01M
Capital expenditure$77,264$96,762—$18,137—
Free cash flow-$2.50M-$2.13M—-$1.54M—
Investing cash flow-$104,450-$147,766—-$268,206-$86.25M
Financing cash flow$2.55M$2.32M$2.35M$2.49M$87.45M
Depreciation & amortization$195,209$173,217$119,348$172,016—

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.